Cases & Deals

Share

Abbott acquires Tendyne Holdings

September 2015

Client(s) Abbott Laboratories

Jones Day acted as tax counsel to Abbott Laboratories in connection with its $250 million acquisition of Tendyne Holdings, Inc., a private medical device company focused on developing minimally invasive mitral valve replacement therapies.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.